Search Results
Aug 12, 2026, 08:44 ET South Africa-China Electricity and Energy Investment Conference Opens at POWERCHINA Headquarters to Advance Long-Term Energy Partnerships
Embassy in China, with support from POWERCHINA, the event brought together more than 260 government, finance and industry representatives to explore over R2.2 trillion in investment opportunities through 2039 under South Africa's Integrated Resource Plan 2025, spanning generation, transmission, energy storage
More news about: POWERCHINA
Aug 12, 2026, 08:43 ET Riverside Theatre Unveils 2026-2027 Season with Six Productions, a World Premiere and a Southeast Premiere
Inaugural season under leadership of Executive Producer & CEO Jon R. MosesVERO BEACH, Fla., Aug. 12, 2026 /PRNewswire/ -- Riverside Theatre, the largest independent nonprofit professional theatre
More news about: Riverside Theatre
Aug 12, 2026, 08:39 ET TCL CSOT Advances Into Professional Esports and Powers the Future of AI Computing at ChinaJoy 2026
begun preliminary research and technical feasibility studies on glass substrates while actively evaluating project construction and collaborative R&D with customers.
More news about: TCL CSOT
Aug 12, 2026, 08:31 ET Dance Theatre of Harlem Galvanizes Arts Community with Inaugural Artistic Council
Robinson, recently Director of Choreography for Beyoncé's Renaissance World Tour, was hailed by The New York Times as "the most elevated hip-hop and R&B choreographer working today."Sanford Biggers is a multidisciplinary artist held in the permanent collections of MoMA and the Guggenheim,
More news about: Dance Theatre of Harlem
Aug 12, 2026, 08:30 ET Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
generative chemistry platform, which integrates more than 40 carefully selected models and multiple supporting application modules. First, Insilico's R&D team uploaded the crystal structure of the target–small molecule complex to the platform to analyze key binding sites and interaction patterns in detail.
More news about: Insilico Medicine
Aug 12, 2026, 08:17 ET Ivonescimab Plus Chemotherapy Approved for First-Line Squamous NSCLC; HARMONi-6 Establishes New Gold Standard in Lung Cancer Treatment
best-in-class innovative biological medicines. Founded in 2012, Akeso has built a comprehensive R&D innovation ecosystem anchored by its proprietary Tetrabody antibody technology platform, AI-powered drug R&D platform, Dual-Shield ADC technology platform, Dual-Lock T-cell engager (TCE) technology platform,
More news about: Akeso, Inc.
Aug 12, 2026, 08:02 ET R-IT3, Inc. Files Four Provisional Patents Defining Precious Metals Recovery-to-Nanomaterials Platform
expenditure on traditional power infrastructure." R-IT3, Inc. is a Certified B Corporation headquartered in Charlotte, North Carolina. Patent examination process is managed by NK Patent Law, with Ani Agrawal as lead attorney.About R-IT3, Inc.R-IT3, Inc. is a domestic precious-metal reclamation
More news about: R-it3,inc
Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin- resistant Staphylococcus
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2026, 08:00 ET Tasman Therapeutics Announces Strategic Partnership with Osmind to Advance R-107 for Depressive Disorders
delivery model that will define how patients experience R-107 tomorrow."About R-107R-107 is an investigational, Phase 3, extended-release oral ketamine tablet being developed as a monotherapy for treatment-resistant depression. R-107 has been studied clinically in Phase 2 and long-term,
More news about: Tasman Therapeutics
Aug 12, 2026, 08:00 ET Amynta Group Announces Agreement to Acquire Southern States Insurance Operations
[email protected] States Media Contact:Jennifer R. GwynPhone: (804) 281-7803Email: [email protected]
More news about: The Amynta Group
Aug 12, 2026, 08:00 ET PagBank reports recurring net income of R$ 576 million in 2Q26, with continued progress across its ecosystem
multimedia:https://www.prnewswire.com/news-releases/pagbank-reports-recurring-net-income-of-r-576-million-in-2q26-with-continued-progress-across-its-ecosystem-302848960.htmlSOURCE
More news about: PagBank
Aug 12, 2026, 08:00 ET PagBank reports recurring net income of R$ 576 million in 2Q26, with continued progress across its ecosystem
content:https://www.prnewswire.co.uk/news-releases/pagbank-reports-recurring-net-income-of-r-576-million-in-2q26-with-continued-progress-across-its-ecosystem-302848959.html
More news about: PagBank
Aug 12, 2026, 08:00 ET PagBank reporta un beneficio neto recurrente de R$ 576 millones en el 2T26, con avances en su ecosistema
multimedia:https://www.prnewswire.com/mx/comunicados-de-prensa/pagbank-reporta-un-beneficio-neto-recurrente-de-r-576-millones-en-el-2t26-con-avances-en-su-ecosistema-302848961.htmlFUENTE
More news about: PagBank
Aug 12, 2026, 08:00 ET PagBank reporta un beneficio neto recurrente de R$ 576 millones en el 2T26, con avances en su ecosistema
multimedia:https://www.prnewswire.com/news-releases/pagbank-reporta-un-beneficio-neto-recurrente-de-r-576-millones-en-el-2t26-con-avances-en-su-ecosistema-302848970.html
More news about: PagBank
Aug 12, 2026, 07:20 ET Frasle Mobility reporta ingresos netos de R$ 1,4 mil millones y margen EBITDA récord en el 2T26
content:https://www.prnewswire.com/mx/comunicados-de-prensa/frasle-mobility-reporta-ingresos-netos-de-r-1-4-mil-millones-y-margen-ebitda-record-en-el-2t26--302849648.htmlFUENTE
More news about: Frasle Mobility
Aug 12, 2026, 07:00 ET Insurify Names Former KAYAK AI Leader Jake Bouvrie as Its First Chief AI Officer
firsthand. Jake combines deep machine learning research with operating experience across insurance, a global consumer marketplace, and enterprise R&D. He's the right leader to help us translate the opportunities of AI into measurable value.""Over the past two decades, AI has moved from research
More news about: INSURIFY, Inc.
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
were concordant across two orthogonal platforms — an aptamer-based SomaScan assay and an antibody-based Meso Scale Discovery (MSD) assay (Spearman r=0.77).Tumoral DKK1 mRNA expression was low in most tissue samples, reinforcing that plasma — not tissue — reflects the systemic DKK1 burden relevant
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 06:50 ET Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
the same periods in 2025. Both periods reflect a $2.1 million grant receivable recorded under the new R&D law as a reduction of R&D expenses. The Company expects to continue to incur R&D expenses as the RELEASE study progresses and additional preclinical and clinical programs advance.Selling,
More news about: Protalix BioTherapeutics, Inc.
Aug 12, 2026, 06:30 ET Bio-Techne Declares Dividend
provides high–quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer–focused brands: R&D Systems™, Bio–Techne Spatial™, and Bio–Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:30 ET Bio-Techne Releases Fourth Quarter Fiscal 2026 Results
provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical
More news about: Bio-Techne Corporation
Aug 12, 2026, 06:06 ET CGTN Spanish: Innovation in Shenzhen: Connecting China with the Asia-Pacific Region
previously could not easily access industrial AI to benefit from it. This is undoubtedly the future trend," said Shi Xiaoliang, Director of Product R&D at SmartMore.At APEC China 2026, with innovation among the region's priorities, Shenzhen will demonstrate how its technology and industrial
More news about: CGTN Spanish
Aug 12, 2026, 06:00 ET Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
six months ended June 30, 2026, net loss was $8.3 million, compared to $3.6 million for the same period in 2025.Research and development (R&D) expenses were $2.8 million for the three months ended June 30, 2026, compared to $0.9 million for the same period in 2025. The increase was primarily
More news about: Eloxx Pharmaceuticals, Inc.
Aug 12, 2026, 05:59 ET Apotex Announces First Quarter 2027 Results
provisions of the Company's share-based compensation in connection with the IPO.R&D expenses were $39 million, up $1 million compared to prior year. R&D spend represented 5% of net sales compared to 3% in prior year. The higher research and development expenses as
More news about: Apotex Health Corp.
Aug 12, 2026, 05:45 ET Odine and OdineLabs File Two Patent Applications Focused on Enterprise AI Technologies
integration, and AI-powered product innovation, has filed two patent applications together with its subsidiary OdineLabs, further strengthening its R&D efforts in artificial intelligence and next-generation software technologies. The applications cover technologies designed to enable AI agents to understand
More news about: Odine
Aug 12, 2026, 05:25 ET Beyang Closes Oversubscribed $30 Million Series A Financing
China, Aug. 12, 2026 /PRNewswire/ -- Beyang Therapeutics Co., Ltd. ("Beyang"), an AI-driven innovative drug R&D company dedicated to building a "DreamWorks" for innovative drug discovery, today announced the successful closing of an oversubscribed Series A financing
More news about: Beyang Therapeutics Co., Ltd.